Oracle Corporation (ORCL): what the price requires
At today's price, Oracle Corporation (ORCL) is priced for +14.1% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Source: https://boothcheck.com/report/ORCL
Headline
| Field | Value |
|---|---|
| Ticker | ORCL |
| Company | Oracle Corporation |
| Current price | $132.25/sh |
| Composition | Cloud and license 86% / Hardware 5% / Services 9% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 11.7% |
| Operating margin today | 30.2% |
| Margin compression implied | -18.5pp |
| Implied growth | 14.1% |
| Multiple paid | 22x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 8.6% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.3pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +0.89σ |
| cohort percentile (of 177 peers) | 38 |
| sustained it ~5 years at this level | 52% |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 2.45x | 5 | expensive |
| Earnings | 2.47x | 3 | expensive |
| Relative | 0.71x | 5 | justifies |
| Growth | 0.72x | 3 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.
Per-Model Detail (n=16)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $314.30 | 0.42x | yes | FCF base $34.2B, growth 17% (input: historical growth), terminal g 4.0%, WACC 8.7%, 6yr projection |
| DCF Exit Multiple | Growth | $183.41 | 0.72x | yes | Exit EV/EBITDA: 15.8x / 17.8x / 19.8x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $195.58 | 0.68x | yes | P/E 35x (static sector reference · 2026-04), scenarios: 28.5x / 35.0x / 41.5x (bear / base = reference held flat / bull), EV/EBITDA 25x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $53.94 | 2.45x | yes | BV/sh $14.60, ROE (TTM) 34.2%, ke 9.3% |
| Two-Stage Excess Return | Asset | $110.07 | 1.20x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $120.85 | 1.09x | yes | Rev $67.4B, growth 17% (input: historical growth; tapered), Terminal P/S: 4.7x / 5.7x / 6.8x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $167.62 | 0.79x | yes | EPS $4.95, growth 34% (input: historical EPS growth), PEG=0.78 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $42.29 | 3.13x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $16.16B × (1−21%) / WACC 8.7% → EPV (no growth) |
| Residual Income | Asset | $83.80 | 1.58x | yes | BV $14.60 + 5yr PV of (ROE (TTM) 34.2% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $40.34 | 3.28x | yes | √(22.5 × EPS $4.95 × BVPS $14.60) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $186.41 | 0.71x | yes | EBITDA $21.96B × sector EV/EBITDA 25.0x |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $159.87 | 0.83x | yes | EPS $4.95 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $16.73 | 7.90x | yes | BV $14.60 × (ROIC 10.0% / WACC 8.7%) |
| P/Sales Sector | Relative | $185.05 | 0.71x | yes | Revenue $67.36B × sector P/S 8.0x |
| PEG Fair Value | Relative | $185.79 | 0.71x | yes | EPS $4.95 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $53.56 | 2.47x | yes | EPS $4.95 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $33.0b |
| Net debt / NOPAT (after-tax) | 2.22x |
| Net debt / operating income (pre-tax) | 1.75x |
| Interest coverage | 4.6x |
| Share count CAGR (dilution) | 1.4% |
| Burning cash | no |
Bullet Takeaways
- At $183.89 (as of June 27, 2026) the price pays roughly 29x company-wide operating income, a level that needs operating profit to compound about 24.8% a year for five years. Oracle has not grown that fast over a full cycle, so the price is a forward bet, not a description of the trailing record.
- The X-ray splits cleanly by family. Growth-DCF and peer-multiple methods land near the price (DCF Perpetual $195, Relative Valuation $187, EV/EBITDA Relative $186), while every asset and earnings-power method sits far below it (Earnings Power Value $46, Simple Excess Return $51, Graham Number $37). The whole case rests on the cloud build paying off.
- The thing that changed the story is the backlog. Remaining performance obligations hit $638 billion at the end of Q4 FY2026, up 363% year over year, and FY2027 revenue is guided to roughly $90 billion. The same quarter carried about $70 billion of guided capex, which is why the stock fell after a clear beat.
Bull Case
Start with what the market is paying for and then check it against the business. At $183.89 the price values Oracle at about 29x company-wide operating income, which works out to an embedded assumption of roughly 24.8% annual operating-profit growth sustained for five years. That is aggressive against Oracle's own multi-decade record. The reason a serious investor can still defend it is that the recent order book has stopped looking like a mature software company's. Remaining performance obligations reached $638 billion at the close of Q4 FY2026, up 363% year over year and up $85 billion sequentially (ERP Today). Revenue that has not yet been recognized at that scale is the closest thing a software model offers to a multi-year forward read, and it is what gives the growth assumption a footing the trailing record cannot provide.
The mix underneath the headline matters. Q4 FY2026 cloud infrastructure revenue grew 93% year over year to $5.8 billion, and management guided FY2027 total revenue up about 34% in constant currency to roughly $90 billion, with Q1 cloud revenue growth of 58% to 64% (Oracle press release). Oracle's filings frame this as a deliberate pivot. In fiscal 2025 it described total cloud and license-support growth led by the Americas, which contributed 75% of the constant-currency growth in that business (FY2025 10-K, accession 0000950170-25-087926). The infrastructure line is now the engine the model is being asked to pay for, and a 93% growth rate alongside a reported 97.5% GPU utilization rate argues the demand is real rather than speculative.
The valuation X-ray supports the optimistic read where it counts. The growth and relative families bracket the price: DCF Perpetual Growth lands at $195, DCF Exit Multiple at $204, Relative Valuation at $187, and EV/EBITDA Relative at $186, all within a few percent of where the stock trades. Against the segment cohort of ServiceNow, Intuit, and Shopify, Oracle is the one with a recognized hyperscale infrastructure backlog rather than a pure subscription book. ServiceNow recognizes its subscription revenue ratably over the contract term (NOW FY2025 10-K, accession 0001373715-26-000007), the same accounting that turns Oracle's $638 billion of obligations into a forward signal rather than a one-time number. If the cloud contracts convert at the rate the backlog implies, the price is defensible, not stretched.
Bear Case
The cleanest place to start the bear case is where the cash is going, because that is what the market reacted to. Oracle beat on Q4 FY2026 revenue and earnings and the stock still fell about 10% (INDmoney). The reason was the funding picture. FY2027 capex is guided at roughly $70 billion to build the data-center capacity behind the backlog. A company spending at that pace to chase contracts, many structured as customer-prepaid or bring-your-own-GPU deals, is converting a software balance sheet into a capital-intensive one. The market is right to ask who carries the financing risk if utilization or pricing slips.
The balance sheet is already feeling the strain. Oracle runs net debt of about $26 billion against gross debt near $65 billion, with interest coverage around 4.7x and a debt structure built on senior notes that rank pari passu with the commercial paper program and the revolving facility (FY2025 10-K, accession 0000950170-25-087926). Free cash flow is the pressure point the X-ray flags directly: the FCF Yield and SBC-adjusted FCF Yield models were both skipped because true free cash flow is non-positive once the build spend is counted. A growth bet financed partly with debt is fine while demand compounds. It is dangerous if the capex runs ahead of the revenue it is meant to capture.
The valuation methods that do not depend on the forward story are blunt about the gap. Earnings Power Value, which asks what the business is worth at current normalized operating earnings with no growth, lands at $46 against a $183.89 price. Simple Excess Return sits at $51, the Graham Number at $37, and ROIC-Justified P/B at $29. These are the conservative, balance-sheet-anchored reads, and they describe what Oracle is today rather than what it is promising to become. The implied 24.8% operating-growth assumption cleared only about 34% of comparable fast-growers when held five years. If conversion of the $638 billion backlog disappoints, or margins compress under the weight of the infrastructure build, the price has a long way to fall back toward the methods that ignore the promise.
Valuation
The valuation reads as a clean split between methods that price the cloud build and methods that ignore it. The average hides the real information, which is the dispersion. The growth family clusters near the price (DCF Perpetual Growth $195, DCF Exit Multiple $204, Discounted Future Market Cap $157), the relative family does too (Relative Valuation $187, EV/EBITDA Relative $186, P/Sales Sector $176), and the asset and earnings-power families sit far below it (Earnings Power Value $46, Simple Excess Return $51, Graham Number $37, ROIC-Justified P/B $29).
Inverting the price tells the same story from the other side. At today's level the market is underwriting roughly 24.8% annual operating-profit growth over five years, computed at an 8.8% cost of capital with 4% terminal growth, where each percentage point of cost of capital moves the implied growth by about 8.1 points. The current price sits above even the high end of that range, consistent with the elevated reading: the price is justified only if you accept the growth and peer-multiple families and dismiss the asset and earnings-power ones. Dividend models are out of the blend because the 1.1% yield falls below the inclusion threshold, and the free-cash-flow yield models drop out because reported free cash flow is non-positive while the build is underway.
Catalysts
Oracle reported Q4 and full-year FY2026 results on June 10, 2026, with total Q4 revenue of $19.2 billion (up 21%), total cloud revenue of $9.9 billion (up 47%), cloud infrastructure revenue of $5.8 billion (up 93%), and non-GAAP EPS of $2.11 (up 24%) (Oracle press release). Remaining performance obligations reached $638 billion, up 363% year over year, and management cited $67 billion of AI infrastructure contracts signed in the quarter with four customers each contracting more than $8 billion (ERP Today).
The forward calendar centers on whether the backlog converts and whether the spend behind it stays funded. FY2027 guidance is for total revenue up about 34% in constant currency to roughly $90 billion, with Q1 FY2027 cloud revenue growth guided at 58% to 64% and capex guided at about $70 billion (TIKR). The Q1 FY2027 print, due in September 2026, is the next test of whether OCI growth holds near the guided range. Three things are worth watching: the pace of RPO conversion into recognized revenue, gross GPU utilization (last reported at 97.5%), and how the capex is financed, since the 10% drop after a beat shows the market is now grading Oracle on cash deployment rather than top-line growth (INDmoney).
Peer Cohorts (Per Segment, With Filing Citations)
Cloud and license (reported)
- MSFT (MICROSOFT CORPORATION)
- (no filing in the citation store)
- CRM (Salesforce, Inc.)
- (no filing in the citation store)
- SAP (SAP SE)
- (no filing in the citation store)
- NOW (ServiceNow, Inc.)
- (no filing in the citation store)
- WDAY (Workday, Inc.)
- (no filing in the citation store)
- SNOW (SNOWFLAKE INC.)
- (no filing in the citation store)
- IBM (INTERNATIONAL BUSINESS MACHINES CORP)
- (no filing in the citation store)
- AMZN (AMAZON COM INC)
- (no filing in the citation store)
Hardware (reported)
- DELL (Dell Technologies Inc.)
- (no filing in the citation store)
- HPE (HEWLETT PACKARD ENTERPRISE COMPANY)
- (no filing in the citation store)
- HPQ (HP INC.)
- (no filing in the citation store)
- NTAP (NetApp, Inc.)
- (no filing in the citation store)
- SMCI (SUPER MICRO COMPUTER, INC.)
- (no filing in the citation store)
- IBM (INTERNATIONAL BUSINESS MACHINES CORP)
- (no filing in the citation store)
Services (reported)
- ACN (Accenture plc)
- (no filing in the citation store)
- CTSH (COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION)
- (no filing in the citation store)
- IBM (INTERNATIONAL BUSINESS MACHINES CORP)
- (no filing in the citation store)
- EPAM (EPAM SYSTEMS, INC.)
- (no filing in the citation store)
- DXC (DXC Technology Co)
- (no filing in the citation store)
- WIT (WIPRO LIMITED)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.